[HTML][HTML] The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
K Sawada, H Chung, S Softic, ME Moreno-Fernandez… - Cell Metabolism, 2023 - cell.com
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an unabated risk factor
for end-stage liver diseases with no available therapies. Dysregulated immune responses …
for end-stage liver diseases with no available therapies. Dysregulated immune responses …
Gender differences in insulin resistance: new knowledge and perspectives
T Ciarambino, P Crispino, G Guarisco… - Current Issues in …, 2023 - mdpi.com
Insulin resistance is the main mechanism in a whole series of pathological conditions, which
are not only of metabolic interest but also of a systemic type. This phenomenon means that …
are not only of metabolic interest but also of a systemic type. This phenomenon means that …
[HTML][HTML] Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments
L Petagine, MG Zariwala, VB Patel - World Journal of …, 2023 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) causes significant global disease burden and is a
leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at …
leading cause of mortality. NAFLD induces a myriad of aberrant changes in hepatocytes at …
Chronic intermittent hypoxia-induced dysmetabolism is associated with hepatic oxidative stress, mitochondrial dysfunction and inflammation
JL Fernandes, FO Martins, E Olea, J Prieto-Lloret… - Antioxidants, 2023 - mdpi.com
The association between obstructive sleep apnea (OSA) and metabolic disorders is well-
established; however, the underlying mechanisms that elucidate this relationship remain …
established; however, the underlying mechanisms that elucidate this relationship remain …
Surfactant protein A promotes western diet-induced hepatic steatosis and fibrosis in mice
Metabolic dysfunction-associated steatotic liver disease (MASLD) remains the most common
cause of liver disease in the United States due to the increased incidence of metabolic …
cause of liver disease in the United States due to the increased incidence of metabolic …
From MASH to HCC: the role of Gas6/TAM receptors
D Apostolo, LL Ferreira, F Vincenzi… - Frontiers in …, 2024 - frontiersin.org
Metabolic dysfunction-associated steatohepatitis (MASH) is the replacement term for what
used to be called nonalcoholic steatohepatitis (NASH). It is characterized by inflammation …
used to be called nonalcoholic steatohepatitis (NASH). It is characterized by inflammation …
Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology
S Ishiyama, M Hayatsu, T Toriumi, H Tsuda… - Scientific Reports, 2024 - nature.com
Abstract Non-alcoholic steatohepatitis (NASH), caused by fat buildup, can lead to liver
inflammation and damage. Elucidation of the spatial distribution of fibrotic tissue in the fatty …
inflammation and damage. Elucidation of the spatial distribution of fibrotic tissue in the fatty …
[HTML][HTML] Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein …
H Yanagisawa, H Maeda, I Noguchi, M Tanaka… - Redox Biology, 2024 - Elsevier
Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of
nonalcoholic fatty liver disease characterised by fat accumulation, inflammation, oxidative …
nonalcoholic fatty liver disease characterised by fat accumulation, inflammation, oxidative …
The PD-1/PD-L1 Axis in the Biology of MASLD
Metabolic Dysfunction-Associated Steatotic Liver (MASL), previously named nonalcoholic
fatty liver (NAFL), is a multifactorial disease in which metabolic, genetic, and environmental …
fatty liver (NAFL), is a multifactorial disease in which metabolic, genetic, and environmental …
[HTML][HTML] Prediction of severe hypertriglyceridemia-associated acute pancreatitis using a nomogram based on CT findings and blood biomarkers
J Dong, Y Shen, Z Wang, J Zhang, X Qin, C Zhu… - Medicine, 2024 - journals.lww.com
Hypertriglyceridemia is a common cause of acute pancreatitis (AP). Fatty liver, a
manifestation of metabolic syndrome, is related to the severity of AP. The present study …
manifestation of metabolic syndrome, is related to the severity of AP. The present study …